These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38677596)

  • 1. Mining clinical data for novel medications to treat alcohol use disorder.
    Rozema L; Hoyt JE; Watts BV; Shiner B
    J Subst Use Addict Treat; 2024 Aug; 163():209381. PubMed ID: 38677596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol-related and mental health care for patients with unhealthy alcohol use and posttraumatic stress disorder in a National Veterans Affairs cohort.
    Chen JA; Owens MD; Browne KC; Williams EC
    J Subst Abuse Treat; 2018 Feb; 85():1-9. PubMed ID: 29291765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification Test-Consumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder.
    Rentsch CT; Fiellin DA; Bryant KJ; Justice AC; Tate JP
    Alcohol Clin Exp Res; 2019 Mar; 43(3):522-530. PubMed ID: 30620410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans.
    Vickers-Smith R; Justice AC; Becker WC; Rentsch CT; Curtis B; Fernander A; Hartwell EE; Ighodaro ET; Kember RL; Tate J; Kranzler HR
    Am J Psychiatry; 2023 Jun; 180(6):426-436. PubMed ID: 37132202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Documented brief intervention associated with reduced linkage to specialty addictions treatment in a national sample of VA patients with unhealthy alcohol use with and without alcohol use disorders.
    Frost MC; Glass JE; Bradley KA; Williams EC
    Addiction; 2020 Apr; 115(4):668-678. PubMed ID: 31642124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Cartwright EJ; Pierret C; Minassian C; Esserman DA; Tate JP; Goetz MB; Bhattacharya D; Fiellin DA; Justice AC; Lo Re V; Rentsch CT
    JAMA Netw Open; 2023 Sep; 6(9):e2335715. PubMed ID: 37751206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining Clinical Data for Novel Posttraumatic Stress Disorder Medications.
    Shiner B; Forehand JA; Rozema L; Kulldorff M; Watts BV; Trefethen M; Jiang T; Huybrechts KF; Schnurr PP; Vincenti M; Gui J; Gradus JL
    Biol Psychiatry; 2022 Apr; 91(7):647-657. PubMed ID: 34952698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic differences in receipt of addictions treatment in a national sample of patients with alcohol use disorders from the U.S. Veterans Health Administration.
    Edmonds AT; Bensley KM; Hawkins EJ; Williams EC
    Subst Abus; 2021; 42(4):559-568. PubMed ID: 32821028
    [No Abstract]   [Full Text] [Related]  

  • 9. Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: Overall and relative to non-transgender patients.
    Williams EC; Chen JA; Frost MC; Rubinsky AD; Edmonds AT; Glass JE; Lehavot K; Matson TE; Wheat CL; Coggeshall S; Blosnich JR
    J Subst Abuse Treat; 2021 Dec; 131():108565. PubMed ID: 34274175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.
    Finlay AK; Ellerbe LS; Wong JJ; Timko C; Rubinsky AD; Gupta S; Bowe TR; Burden JL; Harris AHS
    J Subst Abuse Treat; 2017 Jun; 77():38-43. PubMed ID: 28476269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUDIT-C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations.
    Justice AC; Smith RV; Tate JP; McGinnis K; Xu K; Becker WC; Lee KY; Lynch K; Sun N; Concato J; Fiellin DA; Zhao H; Gelernter J; Kranzler HR;
    Addiction; 2018 Dec; 113(12):2214-2224. PubMed ID: 29972609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: A national study in the U.S. Veterans Health Administration.
    Williams EC; Gupta S; Rubinsky AD; Glass JE; Jones-Webb R; Bensley KM; Harris AHS
    Drug Alcohol Depend; 2017 Sep; 178():527-533. PubMed ID: 28728114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.
    Frost MC; Matson TE; Tsui JI; Williams EC
    Drug Alcohol Depend; 2019 Jan; 194():288-295. PubMed ID: 30469100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of specialty substance use disorder treatment for Department of Veterans Affairs Healthcare System patients with high alcohol consumption.
    Glass JE; Perron BE; Ilgen MA; Chermack ST; Ratliff S; Zivin K
    Drug Alcohol Depend; 2010 Nov; 112(1-2):150-5. PubMed ID: 20656425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between race and ethnicity and receipt of advice about alcohol use in the Department of Veterans Affairs.
    Dobscha SK; Dickinson KC; Lasarev MR; Lee ES
    Psychiatr Serv; 2009 May; 60(5):663-70. PubMed ID: 19411355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of alcohol use disorders in US military veterans: results from the National Health and Resilience in Veterans Study.
    Fuehrlein BS; Mota N; Arias AJ; Trevisan LA; Kachadourian LK; Krystal JH; Southwick SM; Pietrzak RH
    Addiction; 2016 Oct; 111(10):1786-94. PubMed ID: 27061707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration.
    Taylor E; Timko C; Harris AHS; Yu M; Finlay AK
    Addict Sci Clin Pract; 2019 Jan; 14(1):1. PubMed ID: 30602392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.